<--- Back to Details
First PageDocument Content
HIV/AIDS / Immune system / Chemokine receptors / CCR5 / Toxoplasma gondii / Macrophage / Chemokine / Green fluorescent protein / CCL2 / Biology / Cytokines / Apicomplexa
HIV/AIDS
Immune system
Chemokine receptors
CCR5
Toxoplasma gondii
Macrophage
Chemokine
Green fluorescent protein
CCL2
Biology
Cytokines
Apicomplexa

In Silico identification of pathogenic strains of Cronobacter from Biochemical data reveals association of inositol fermentation with pathogenicity

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 1,46 MB

Share Document on Facebook

Similar Documents

D E PA R T M E N T O F N E U R O S C I E N C E A N D P H A R M A C O L O G Y FACULTY OF HEALTH AND MEDICAL SCIENCES, UNIVERSITY OF COPENHAGEN INF RMATION MINDS MAKE MOLECULES – MOLECULES MAKE SENSE

D E PA R T M E N T O F N E U R O S C I E N C E A N D P H A R M A C O L O G Y FACULTY OF HEALTH AND MEDICAL SCIENCES, UNIVERSITY OF COPENHAGEN INF RMATION MINDS MAKE MOLECULES – MOLECULES MAKE SENSE

DocID: 1p8jU - View Document

Kernel-based Methods for Relation Extraction Yifan Peng Computer & Information Sciences University of Delaware Nov 3, 2014

Kernel-based Methods for Relation Extraction Yifan Peng Computer & Information Sciences University of Delaware Nov 3, 2014

DocID: 1oPD7 - View Document

Article  Discovery and Characterization of an Endogenous CXCR4 Antagonist Graphical Abstract

Article Discovery and Characterization of an Endogenous CXCR4 Antagonist Graphical Abstract

DocID: 1fwra - View Document

Turning Spiegelmers into Drugs NOXXON Pharma is a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers*, the chemically synthesized, immunologically passive a

Turning Spiegelmers into Drugs NOXXON Pharma is a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers*, the chemically synthesized, immunologically passive a

DocID: 1a5Tb - View Document

analysis  from the makers of and

analysis from the makers of and

DocID: 19mhM - View Document